Taste and Smell Abnormalities as an Independent Cause of Failure of Food Intake in Patients with Advanced Cancer—an Argument for the Application of Sensory Science
Restricted accessOtherFirst published online June, 2006
Taste and Smell Abnormalities as an Independent Cause of Failure of Food Intake in Patients with Advanced Cancer—an Argument for the Application of Sensory Science
MelaD.J.Food choice and intake: the human factor. Proc Nutr Soc1999; 58(3): 513–521.
2.
de CastroJ.M., BellisleF., DalixA.M., PearceyS.M.Palatability and intake relationships in free-living humans. characterization and independence of influence in North Americans. Physiol Behav2000; 70(3-4): 343–350.
3.
SpanagelR., WeissF.The dopamine hypothesis of reward: past and current status. Trends Neurosci1999; 22(11): 521–527.
ShepherdR.Social determinants of food choice. Proc Nutr Soc1999; 58(4): 807–812.
6.
DrewnowskiA.Taste preferences and food intake. Annu Rev Nutr1997; 17: 237–253.
7.
RhodesV.A., McDanielR.W., HansonB., MarkwayE., JohnsonM.Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nurs1994; 17(1): 45–51.
8.
KomurcuS., NelsonK.A., WalshD., FordR.B., RybickiL.A.Gastrointestinal symptoms among Inpatients with advanced cancer. Am J Hosp Palliat Care2002; 19(5): 351–355.
9.
LindleyC., McCuneJ.S., ThomasonT.E., LauderD., SaulsA., AdkinsS., SawyerW.T.Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract1999; 7(2): 59–65.
HuttonJ.Diet Patterns and Chemosensory Perception in Advanced Cancer.Edmonton, Alberta: University of Alberta, 2005.
12.
StubbsL.Taste changes in cancer patients. Nurs Times1989; 85(3): 49–50.
13.
NielsenS.S., TheologidesA., VickersZ.M.Influence of food odors on food aversions and preferences in patients with cancer. Am J Clin Nutr1980; 33(11): 2253–2261.
14.
DeWysW.D., WaltersK.Abnormalities of taste sensation in cancer patients. Cancer1975; 38(5): 1888–1896.
15.
GrosvenorM., BulcavageL., ChlebowskiR.T.Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer1989; 63(2): 330–334.
16.
MattesR.D., CowartB.J., SchlavoM.A., ArnoldC., GarrisonB., KareM.R., LowryL.D.Dietary evaluation of patients with smell and/or taste disorders. Am J Clin Nutr1990; 51(2): 233–240.
17.
SchiffmanS.S.Taste and smell in disease (first of two parts). N Engl J Med1983; 308(21): 1275–1279.
18.
Mattes-KuligD.A., HenkinR.I.Energy and nutrient consumption of patients with dysgeusia. J Am Diet Assoc1985; 85(7): 822–826.
19.
EstremS., RennerG.Disorders of smell and taste. Otolaryngol Clin North Am1987; 20(1): 133–147.
20.
RipamontiC., ZeccaE., BrunelliC., FulfaroF., VillaS., BalzariniA., BombardieriE., De ConnoF.A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck Irradiation. Cancer1998; 82(10): 1938–1945.
21.
SilvermanJ.E., WeberC.W., SilvermanS.Jr., CoulthardS.L., ManningM.R.Zinc supplementation and taste in head and neck cancer patients undergoing radiation therapy. J Oral Med1983; 38(1): 14–16.
22.
WitteK.K., ClarkA.L.Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol2002; 85(1): 23–31.
23.
StrasserF., BrueraE.D.Update on anorexia and cachexia. Hematol Oncol Clin North Am2002; 16(3): 589–617.
24.
DavidsonH.I., PattisonR.M., RichardsonR.A.Clinical undernutrition states and their influence on taste. Proc Nutr Soc1998; 57(4): 633–638.
25.
RipamontiC., FulfaroF.Taste alterations in cancer patients. J Pain Symptom Manage1998; 16(6): 349–351.
26.
VanderA., ShermanJ., LucianoD.Human Physiology: the mechanisms of body function. 8th edition. New York: McGraw Hill Companies, 2001.
27.
HuldijA., GiesbersA., Klein PoelhuisE.H., HartA.A., HulshofK.F., BruningP.F.Alterations in taste appreciation in cancer patients during treatment. Cancer Nurs1986; 9(1): 38–42.
28.
BoakesR.A., TarrierN., BarnesB.W., TattersallM.H.Prevalence of anticipatory nausea and other side-effects in cancer patients receiving chemotherapy. Eur J Cancer1993; 29A(6): 866–870.
29.
SeligmanP.A., FinkR., Massey-SeligmanE.J.Approach to the seriously ill or terminal cancer patient who has a poor appetite. Semin Oncol1998; 25(2 Suppl 6): 33–34.
30.
McClementS.E., DegnerL.F., HarlosM.Family responses to declining intake and weight loss in a terminally ill relative. Part 1: Fighting back. J Palliat Care2004; 20(2): 93–100.
31.
MorleyJ.E.Orexigenic and anabolic agents. Clin Geriatr Med2002; 18(4): 853–866.
32.
InuiA.Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin2002; 52(2): 72–91.
33.
MacDonaldN., EassonA.M., MazurakV.C., DunnG.P., BaracosV.E.Understanding and managing cancer cachexia. J Am Coll Surg2003; 197(1): 143–161.
34.
JatoiA., KumarS., SloanJ.A., NguyenP.L.On appetite and its loss. J Clin Oncol2000; 18(15): 2930–2932.
35.
OtteryF.D.Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition1996; 12(1 Suppl): S15–S19.
36.
HealdA.E., PleperC.F.Schiffman SS. Taste and smell complaints in HIV-infected patients. AIDS1998; 12(13): 1667–1674.
37.
SeidenA.M.Taste and Smell Disorders.New York: Thieme, 1997.
38.
CainW.S., GentJ., CatalanottoF.A., GoodspeedR.B.Clinical evaluation of olfaction. Am J Otolaryngol1983; 4(4): 252–256.
39.
DotyR.L., ShamanP., DannM.Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav1984; 32(3): 489–502.
40.
VickersZ.M., NielsenS.S., TheologidesA.Food preferences of patients with cancer. J Am Diet Assoc1981; 79(4): 441–445.
41.
SorensenL.B., MollerP., FlintA., MartensM., RabenA.Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. Int J Obes Relat Metab Disord2003; 27(10): 1152–1166.
42.
SchiffmanS.S.Taste and smell in disease (second of two parts). N Engl J Med1983; 308(22): 1337–1343.
43.
NelsonK., WalshD., DeeterP., SheehanF.A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care1994; 10(1): 14–18.
44.
JatoiA., WindschitlH.E., LoprinziC.L., SloanJ.A., DakhilS.R., MailliardJ.A.Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol2002; 20(2): 567–573.
45.
RegelsonW., ButlerJ.R., SchulzJ., KirkT., PeekL., GreenM.L., ZalisM.O.Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients.New York: Raven Press, 1976.
46.
BealJ.E., OlsonR., LaubensteinL., MoralesJ.O., BellmanP., YangcoB.Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage1995; 10(2): 89–97.
47.
WilliamsC.M., KirkhamT.C.Observational analysis of feeding induced by delta-9-THC and anandamide. Physiol Behav2002; 76(2): 241–250.
48.
ArnoneM., MaruaniJ., ChaperonF., ThiebotM.H., PonceletM., SoubrieP., Le FurG.Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl)1997; 132(1): 104–106.
49.
RollsB.J.Aging and appetite. Nutr Rev1992; 50(12): 422–426.
50.
RavascoP., Monteiro-GrilloI., VidalP.M., CamiloM.E.Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol2005; 23(7): 1431–1438.
51.
SchiffmanS.S.Intensification of sensory properties of foods for the elderly. J Nutr2000; 130(4S Suppl): 927S–930S.
52.
SchiffmanS.S.Taste and smell losses in normal aging and disease. JAMA1997; 278(16): 1357–1362.